ISO/TR 19024:2016

Evaluation of CPB devices relative to their capabilities of reducing the transmission of gaseous microemboli (GME) to a patient during cardiopulmonary bypass

Publication date: Aug 12, 2016

General information

Current stage: 60.60 Effective date: Aug 12, 2016

Originator: ISO

Owner: ISO/TC 150/SC 2

Type: Technical Report

ICS: 11.040.40

Languages: English

Buying

Status: Published

PDF - EC$183.61

Paper - EC$183.61

PDF and Paper - EC$367.22

Language

Language in which you want to receive the document.

Scope

ISO/TR 19024:2016 recommends acceptable methodology for conducting gaseous microemboli (GME) testing and discusses limitations of current test methods. Tests described in ISO/TR 19024:2016 are limited to those conducted using an in vitro circulatory system.
It is applicable to all devices intended for extracorporeal circulatory support during cardiopulmonary bypass (CPB). It outlines approaches currently used to assess the ability of CPB devices to handle GME.

Life cycle

NOW

PUBLISHED
ISO/TR 19024:2016
60.60 Standard published
Aug 12, 2016

Preview

Only informative sections of projects are publicly available. To view the full content, you will need to members of the committee. If you are a member, please log in to your account by clicking on the "Log in" button.